Anecdotal support for this endothelial-to-leukocyte transfer hypothesis is further provided by observations of Mandel et al. [20] who noted that, while levels of CLN-5 were elevated in PBLs of MS patients in the relapse state, CLN-5 status was unaffected by in vitro activation of these cells. Here, CLN5 is linked to myeloid sarcoma.